EP3666283
FACTOR VIII POLYPEPTIDE FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.3.2014EP published:
8.6.2022EP application number:
19212900.5
EPO information:
European Patent Register
Max expiry date:
13.3.2034
Title in English:
FACTOR VIII POLYPEPTIDE FORMULATIONSLanguage of the patent:
English
Timeline
Today
14.3.2014EP application
8.6.2022EP Publication
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, Waltham MA 02451, US
Inventor
Name:
MALONEY, KevinAddress:
Cambridge, MA Massachusetts 02142, US
Name:
ABDUL-FATTAH, AhmadAddress:
Cambridge, MA Massachusetts 02142, US
Name:
GAGE, DanielAddress:
Cambridge, MA Massachusetts 02142, US
Priority
Number:
201361800293 PDate:
15.3.2013Country:
US
Number:
201361817085 PDate:
29.4.2013Country:
US
Number:
201361829884 PDate:
31.5.2013Country:
US
Number:
201361839477 PDate:
26.6.2013Country:
US
Number:
201361863860 PDate:
8.8.2013Country:
US
Number:
201361876927 PDate:
12.9.2013Country:
US
Number:
201361879955 PDate:
19.9.2013Country:
US
Number:
201361897742 PDate:
30.10.2013Country:
US
Classification
Categories:
A61K 38/37, A61P 7/00, A61P 7/04, A61P 43/00